Propofol induces apoptosis of breast cancer cells by downregulation of miR-24 signal pathway

Cancer Biomark. 2018 Feb 14;21(3):513-519. doi: 10.3233/CBM-170234.

Abstract

Background and objective: Propofol, an intravenous anesthetic agent, has been found to inhibit growth of breast cancer cells. However, the mechanisms underlying the antitumor are not known. A recent report has found that propofol could significantly downregulate miR-24 expression in the human malignant cancers. In breast cancer cells, overexpression of miR-24 promotes cell proliferation and inhibits cell apoptosis by downregulation of p27. The miR-24 has been reported to be overexpressed in breast cancer and breast cancer cell lines. In the present study, we hypothesized that propofol induces apoptosis of breast cancer cells by miR-24/p27 signal pathway.

Methods: Breast cancer MDA-MB-435 cells were exposed to propofol (10 μM) for 6 hr and cell death was assessed using TUNEL staining, Flow cytometry and cleaved caspase-3 expression. microRNA-24 (miR-24) expression was assessed using quantitative reverse transcription polymerase chain reaction (qRT-PCR). miR-24 was overexpressed using a miR-24 mimic. P27 was knocked down using a small interfering RNA. p27 and cleaved caspase-3 expression was assessed by Western blot.

Results: MDA-MB-435 exposed to propofol showed a significant increase in apoptotic cells, followed by the downregulation of miR-24, upregulation of p27 expression and cleaved caspase-3 expression. Targeting p27 inhibits propofol-induced cell apoptosis; miR-24 overexpression decreased propofol-induced cell apoptosis, cleaved caspase-3 and p27 expression.

Conclusions: Propofol inducescell death in MDA-MB-435 cells via inactivation of miR-24/p27 signal pathway.

Keywords: Propofol; breast cancer; miR-24; p27.

MeSH terms

  • Anesthetics, Intravenous / pharmacology
  • Apoptosis / drug effects*
  • Apoptosis / genetics*
  • Breast Neoplasms / genetics*
  • Breast Neoplasms / metabolism
  • Cell Death / drug effects
  • Cell Death / genetics
  • Cell Line, Tumor
  • Cyclin-Dependent Kinase Inhibitor p27 / genetics
  • Cyclin-Dependent Kinase Inhibitor p27 / metabolism
  • Down-Regulation
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Humans
  • MicroRNAs / genetics*
  • Propofol / pharmacology*
  • Signal Transduction / drug effects

Substances

  • Anesthetics, Intravenous
  • MIRN24 microRNA, human
  • MicroRNAs
  • Cyclin-Dependent Kinase Inhibitor p27
  • Propofol